Diabetes mellitus and exocrine pancreatic function by Göke, B.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Editorial 
 Digestion 2005;72:69–70 
 DOI: 10.1159/000087659 
 Diabetes mellitus and Exocrine 
Pancreatic Function 
 Burkhard Göke 
 Department of Internal Medicine, Klinikum Grosshadern, University of Munich,  Munich , Germany 
lary circulation and thereby reduces islet perfusion. Inter-
estingly, in tropical countries and India a special form of 
non-alcoholic tropical calcifying pancreatitis leads to 
DM. Although little is known about the exact etiology of 
this form of diabetes it has been found that the   -cell func-
tion is damaged whereas the   cells are preserved  [6, 7] . 
This is in contrast to the non-tropical chronic pancreatitis 
where both cell populations are altered. In any case, two 
different pathogenic mechanisms have been proposed, 
one eliciting CP and the other selective pancreatic   -cell 
impairment and subsequent DM. DM caused by chronic 
infl ammation of the exocrine pancreas develops typically 
in 80% of the patients within the fi rst 10 years after the 
initial diagnosis of chronic pancreatitis  [8] . Chronic cal-
cifying pancreatitis (60–70%) leads to diabetes more of-
ten than non-calcifying pancreatitis (15–30%)  [2, 9] . The 
duration of CP plays an important role: the continuing 
infl ammatory-fi brotic disturbance of exocrine and endo-
crine tissue, with a signifi cant loss of   cells and hence a 
progressive decrease in insulin-secretion, triggers overt 
DM. DM occurs when approximately 80% of the   cells 
are destroyed  [10] . 
 One can try to explain the occurrence of pancreatic 
exocrine dysfunction as a complication of preexisting di-
abetes .  However, only in a few patients do overt DM 
symptoms precede a later fi nding of chronic pancreatitis. 
It is rather questionable whether DM is the reason for CP 
rather than CP being oligosymptomatic and allowing DM 
to become overt somewhat earlier. Anyway, this may lead 
to an initial misclassifi cation  [11, 12].  Overall, it seems 
 About one million endocrine islets are scattered 
throughout the human exocrine pancreas. An islet is com-
posed of about fi ve thousand endocrine cells and the 
whole body of islets accounts for 1–2% of the volume of 
the pancreas. An islet contains four major types of endo-
crine cells, a majority of insulin-producing   cells, less 
glucagon-producing   cells, and fewer   (somatostatin) 
and pancreatic polypeptide cells. It has a certain tradition 
that gastroenterologists study the exocrine pancreas 
whereas endocrinologists study the endocrine pancreas. 
This goes so far that the pancreas is often regarded as two 
separate organs. However, clinical observations clearly 
show that disturbances of the exocrine gland impact on 
endocrine cells. 
 Patients with chronic pancreatitis (CP) often suffer 
from endocrine pancreatic dysfunction. This even leads 
to a distinct secondary type of diabetes  [1] . Diabetes mel-
litus (DM) secondary to CP accounts for  ! 1% of all dia-
betes cases, which is probably the reason why it is not of 
that much interest to most diabetologists. On the other 
hand, 80% of patients with CP develop an overt DM in 
the long run and DM is an independent risk factor for 
mortality in patients with CP  [2–4] . This makes this form 
of DM relevant to the gastroenterologist. The most fre-
quent cause of secondary DM in patients with pancreatic 
diseases in the Western hemisphere is chronic alcoholic 
pancreatitis  [5] . Its occurrence is attributed to the close 
anatomical and functional links between the exocrine and 
endocrine pancreas. It is believed that CP, progressively 
developing fi brosis and sclerosis, alters pancreatic capil-
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unlikely that DM is a true risk factor of chronic pancre-
atitis in the vast majority of patients. Whether newly de-
veloping concepts of the pathogenesis of chronic pancre-
atitis will shed more light onto this question is so far only 
speculative  [13] . 
 However, a wealth of physiological evidence has been 
collected that, together with earlier morphological evi-
dence, indicates that islet hormones regulate the exocrine 
pancreas  [14] . The underlying observation is that an islet-
acinar portal blood system exists carrying endocrine cell 
products such as insulin (and also other peptides) to the 
acinar cells. In experimental diabetes the makeup of di-
gestive enzymes changes and solid data prove that the 
mRNA for insulin is reduced following a lack of insulin. 
In the present issue of  Digestion an interesting follow-up 
study by Creutzfeldt and co-workers appears following a 
collective of patients with type-1 DM. More than two de-
cades ago  Digestion published a paper dealing with this 
collective  [15] in whom an abnormal secretin-pancreozy-
min function test was found in a signifi cant proportion of 
23 of 53 patients. From the original study population 20 
persons could be recruited into a follow-up examination 
of their exocrine pancreatic function. These data are now 
again being published in  Digestion  [16] . The time interval 
between the initial and the follow-up tests ranged from 9 
to 23 years. Certainly, the present study has obvious lim-
itations; less than 50% of the original collective were re-
investigated and no data on the metabolic control of dia-
betes (HBA1c, etc.) are available. Still, the data hint that 
exocrine pancreatic insuffi ciency is not a clinically rele-
vant late complication of type-1 diabetes. It suggests that 
mild to moderate exocrine pancreatic insuffi ciency may 
be due to an early event in the course of autoimmune 
diabetes and does not progress. This early phase during 
the onset of type-1 diabetes with an affi nity for both parts 
of the gland is still a matter of ongoing research. 
 Autoimmune events are under consideration for the 
development of chronic pancreatitis per se. Still, the 
pathophysiological mechanisms between type-1 diabetes 
and autoimmune chronic pancreatitis are probably dis-
tinct. In any case, when handling diabetic patients an in-
creasing insulin defi ciency is substituted by exogenous 
insulin delivery. The latter obviously makes up for the 
lack of insulin regulating exocrine pancreatic acini and 
exocrine function. 
 The data presented here stress the notion that follow-
up studies of exocrine pancreatic function are unneces-
sary in type-1 diabetes on a routine basis. 
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